2025年,全球生物医药行业在经历了一段时期的调整后,迎来了一个崭新的发展周期。在这一进程中,业务发展(Business Development, BD)已不仅是药企补充管线的手段,更成为了衡量企业创新能力与国际化水平的核心指标。特别是中国药企,凭借卓越的研发效率与资产质量,正在全球BD舞台上发挥着举足轻重的作用 。本文将基于药渡咨询的深度调研数据,对2025年全球及中国创新药BD交易的全景进行...
Source Link2025年,全球生物医药行业在经历了一段时期的调整后,迎来了一个崭新的发展周期。在这一进程中,业务发展(Business Development, BD)已不仅是药企补充管线的手段,更成为了衡量企业创新能力与国际化水平的核心指标。特别是中国药企,凭借卓越的研发效率与资产质量,正在全球BD舞台上发挥着举足轻重的作用 。本文将基于药渡咨询的深度调研数据,对2025年全球及中国创新药BD交易的全景进行...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.